logo

For the Inventor, By the Inventor

Kalamazoo, MI, United States of America

Jerry R Colca

This inventor holds 7 USPTO granted patents. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co., Biovitrum Ab. Active years: 1994-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerry R Colca. Retrieved from https://idiyas.com/inventor/jerry-r-colca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 85.7

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 82(Granted Patents)


Location History:

  • Texas Township, MI (US) (1995)
  • Kalamazoo, MI (US) (1994 - 2003)

Company Filing History:

goldMedal4 out of 523 
 
Pharmacia & Upjohn Company
 patents
silverMedal2 out of 2,170 
 
The Upjohn Co.
 patents
bronzeMedal1 out of 55 
 
Biovitrum Ab
 patents
4. 1 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1994-2003

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6573291 - Method and use (2003-06-03),
2. 5929101 - Use of insulin sensitizing agents to treat hypertension (1999-07-27),
3. 5814670 - Use of insulin sensitizing agents to treat hypertension (1998-09-29),
4. 5723476 - 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus (1998-03-03),
5. 5719188 - Use of insulin sensitizing agents to treat hypertension (1998-02-17),
6. 5441971 - Thiazolidinedione derivatives, production and use thereof (1995-08-15),
7. 5356913 - Use of insulin sensitizing agents to treat hypertension (1994-10-18),

Title: Jerry R Colca: Innovator in Insulin Sensitizing Agents

Introduction

Jerry R Colca is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of hypertension in insulin-resistant patients. With a total of 7 patents to his name, Colca's work has had a meaningful impact on healthcare.

Latest Patents

One of Jerry R Colca's latest patents is titled "Method and use - Use of insulin sensitizing agents to treat hypertension." This invention provides a method for treating hypertension in insulin-resistant patients through the administration of insulin sensitizing agents, specifically ciglitazone or pioglitazone. This innovative approach aims to improve the quality of life for individuals suffering from both hypertension and insulin resistance.

Career Highlights

Throughout his career, Colca has worked with prominent companies such as Pharmacia & Upjohn Company and The Upjohn Company. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Jerry R Colca has collaborated with notable individuals in his field, including Takashi Sohda and Hitoshi Ikeda. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

In summary, Jerry R Colca is a distinguished inventor whose work in insulin sensitizing agents has the potential to transform the treatment of hypertension in insulin-resistant patients. His contributions to the field are invaluable and continue to influence medical practices today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…